Dn B Asset Management As Nuvasive Inc Transaction History

Dn B Asset Management As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 13, 2020	SELL	$60.96 - $77.7 $4.39 Million - $5.59 Million	-72,000 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$55.78 - $68.08 $557,800 - $680,800	-10,000 Reduced 12.2%	72,000 $4.56 Million
Q2 2019 Jul 08, 2019	SELL	$53.69 - $65.47 $4.61 Million - $5.62 Million	-85,900 Reduced 51.16%	82,000 $0
Q1 2019 Apr 11, 2019	SELL	$44.53 - $58.9 $3.71 Million - $4.91 Million	-83,400 Reduced 33.19%	167,900 $0
Q4 2018 Jan 15, 2019	BUY	$47.64 - $71.26 $6.41 Million - $9.58 Million	134,500 Added 115.15%	251,300 $12.5 Million
Q3 2018 Oct 10, 2018	SELL	$52.03 - $71.41 $3.01 Million - $4.13 Million	-57,800 Reduced 33.1%	116,800 $0
Q2 2018 Jul 06, 2018	BUY	$48.15 - $56.68 $664,470 - $782,184	13,800 Added 8.58%	174,600 $0
Q4 2017 Jan 10, 2018	BUY	$50.58 - $60.79 $8.13 Million - $9.78 Million	160,800	160,800 $0

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

Stay updated on Dn B Asset Management As with notifications on news.